Watch Ticker

Alterity Therapeutics Limited American Depositary Shares

Go to Alterity Therapeutics Limited American Depositary Shares Website

$5.41

0.20 (3.84%)

Live

Previous Close

$5.21

Day Range

$5.2102 - $5.44

Previous Day Range

$5.09 - $5.339

Market Cap

$74.2 million USD

Day Vol.

35465

Previous Day Vol.

24925

Currency

USD

Primary Exchange

Nasdaq

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Delveinsight - Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight

The article discusses the growing pipeline of alpha-synuclein inhibitors, a class of investigational therapies targeting the aggregation of alpha-synuclein, a protein implicated in neurodegenerative diseases. The pipeline includes over 20 active players and 22+ pipeline therapies, with several promising candidates in various stages of clinical trials.

Related tickers: ANVS, ATHE, DNLI, HLBAY, ABBV, AZN, PRTA, RHHBY, PMN.

Read Full Article

Delveinsight - Tau Inhibitors Clinical Trial Pipeline Analysis Demonstrates 25+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight

The rising incidence of Alzheimer's and other tau-related disorders is driving the demand for tau-targeting therapies. Innovative approaches, particularly small molecules that inhibit tau aggregation, are at the forefront of R&D. Increased funding is accelerating advancements in neurodegenerative disease treatments, positioning tau inhibitors as a key market driver.

Related tickers: IONS, ATHE, VYGR, PRTA.

Read Full Article

Trending Tickers

Please sign in to view